Parx Plastics has announced positive results of its antimicrobial incorporation trials with BASF Terluran GP-35 ABS copolymer. Terluran is a standard ABS grade with a low viscosity used in a wide range of applications. ISO 22196 testing by a TÜV-certified laboratory show an antimicrobial effect of 98-99% for Escherichia Coli (Gram-) and Staphilococcus Aurus (Gram+) bacteria, using technology incorporated by Parx Plastics. Terluran GP-35 is available throughout the world and can now incorporate an effective antimicrobial property.

The technology allows the creation of ‘Sanipolymers’ by incorporating a bodily own trace element providing an effective antibacterial property. The technology can be applied to any (co-)polymer and offers a safe and non-toxic alternative to options such as (nano-)silver, chemicals (e.g. Triclosan) or the use of nano-particles. Parx Plastics claims that the effectiveness levels reach as high as 98-99% after 24 hours following the ISO 22196 or JIS Z 2801 testing guidelines and works effectively against Staphylococcus Aureus, Escherichia Coli, MRSA, Clostridium Difficile and many others. The technology also reportedly shows no migration properties.